Regenxbio Inc (RGNX)
7.63
+0.22
(+2.97%)
USD |
NASDAQ |
Dec 20, 16:00
7.71
+0.08
(+1.05%)
After-Hours: 20:00
Regenxbio Shareholders Equity (Quarterly): 301.42M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 660.94M |
| Vertex Pharmaceuticals Inc | 15.63B |
| Sarepta Therapeutics Inc | 1.221B |
| Edgewise Therapeutics Inc | 488.88M |
| Entrada Therapeutics Inc | 422.45M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 519.11M |
| Total Liabilities (Quarterly) | 217.70M |
| Current Ratio | 3.051 |